|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,630.00 INR | +3.80% |
|
-2.32% | +109.24% |
| Market Cap | 23.97B 249M 218M 201M 185M 349M 356M 2.4B 944M 11.74B 935M 914M 40.41B | P/E 2024 |
29.8x | P/E 2025 | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 17.65B 183M 160M 148M 136M 257M 262M 1.77B 695M 8.64B 688M 673M 29.76B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 3.67x |
| Free-Float |
27.09% | Yield 2024 |
2.43% | Yield 2025 | 3.18% |
| 1 day | +3.80% | ||
| 1 week | -2.32% | ||
| Current month | +13.59% | ||
| 1 month | +9.33% | ||
| 3 months | +63.65% | ||
| 6 months | +108.83% | ||
| Current year | +109.24% |
| 1 week | 1,508.15 |  | 1,722.2 |
| 1 month | 1,390.3 | | 1,722.2 |
| Current year | 750 | | 1,722.2 |
| 1 year | 750 | | 1,722.2 |
| 3 years | 599.95 | | 1,722.2 |
| 5 years | 554 | | 1,722.2 |
| 10 years | 420.05 | | 1,722.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shilpa Joshi
DFI | Director of Finance/CFO | - | 2022-04-30 |
Chandni Maru
CMP | Compliance Officer | - | 2024-05-07 |
Amitabh Dube
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2008-07-31 | |
| Director/Board Member | 66 | 2020-06-21 | |
Shilpa Joshi
BRD | Director/Board Member | - | 2022-11-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.80% | -2.32% | +52.89% | +96.15% | 403M | |
| +0.85% | -0.80% | +52.79% | +159.97% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.41% | 609B | |
| +0.04% | +2.58% | +34.47% | +84.84% | 450B | |
| +0.78% | -0.71% | +29.28% | +23.25% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.53% | 284B | |
| -0.27% | -1.87% | +22.34% | +19.92% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.01% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.85% | 198B | |
| -1.48% | +3.43% | +24.08% | +70.06% | 167B | |
| Average | +0.32% | +1.02% | +30.97% | +57.40% | 357.55B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +78.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.35B 34.79M 30.41M 28.06M 25.86M 48.75M 49.83M 335M 132M 1.64B 131M 128M 5.65B | 3.56B 37M 32.33M 29.83M 27.5M 51.83M 52.98M 357M 140M 1.74B 139M 136M 6.01B |
| Net income | 852M 8.85M 7.73M 7.13M 6.58M 12.39M 12.67M 85.27M 33.54M 417M 33.22M 32.49M 1.44B | 1.01B 10.48M 9.16M 8.45M 7.79M 14.68M 15M 101M 39.72M 494M 39.35M 38.48M 1.7B |
| Net Debt | -5.78B -60.02M -52.45M -48.4M -44.61M -84.09M -85.96M -579M -228M -2.83B -225M -220M -9.75B | -6.32B -65.63M -57.35M -52.92M -48.78M -91.95M -93.99M -633M -249M -3.1B -246M -241M -10.66B |
Employees
56
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | ₹1,630.00 | +3.80% | 1,410 |
| 26-07-17 | ₹1,570.30 | -2.06% | 2,632 |
| 26-07-16 | ₹1,603.40 | +3.56% | 3,740 |
| 26-07-15 | ₹1,548.25 | -4.32% | 2,865 |
| 26-07-14 | ₹1,618.10 | -3.04% | 8,790 |
- Stock Market
- Stocks
- NOVARTIND Stock
Select your edition
All financial news and data tailored to specific country editions
